US SEC Filings Daily Market Digest — March 11, 2026

11-03-2026

ON Semiconductor Corporation (onsemi) announced on March 9, 2026, that Simon Keeton, Group President of the Power Solutions Group, will resign from all employment positions effective June 30, 2026, immediately stepping down from officer roles but remaining to ensure an orderly transition. Keeton joined onsemi in July 2007 and assumed his current role in February 2024. The filing was signed by Paul Dutton, Senior Vice President, Chief Legal Officer and Secretary.

• ·Agreement reached on March 9, 2026
• ·Filing submitted on March 11, 2026

11-03-2026

ICL Group Ltd. reported strong operating cash flow of $1,056 million in 2025 and declared total dividends of $232 million, reflecting a 3.1% yield based on average share price. Reported operating income grew significantly YoY to $1,141 million in 2025 from $775 million prior year (+47%), and adjusted net income rose to $715 million (+48% YoY). However, adjusted operating income remained flat at $873 million between the first two years before increasing to $1,218 million, with notable adjustments including $131 million in impairments/write-offs and $54 million in security-related charges.

• ·Zin site life of mine: 2026 to 2040 based on 3 Mt reserves of low organic phosphate.
• ·Charges related to security situation in Israel: $54M (2023), $57M (2024), $14M (2025).
• ·Legal proceedings, dispute, and other settlement expenses: $80M (2023), $2M (2024), -$2M (2025).

11-03-2026

GameSquare Holdings, Inc. received a second Nasdaq notice on March 10, 2026, granting an additional 180 calendar days until September 7, 2026, to regain compliance with the $1.00 minimum bid price rule after failing the initial 180-day period ending March 9, 2026. The company meets other Nasdaq Capital Market listing requirements except bid price and plans a potential reverse stock split. However, failure to achieve $1.00 closing bid price for 10-20 consecutive business days risks delisting, with no assurance of compliance.

• ·Initial deficiency notice received September 10, 2025, for 30 consecutive business days below $1.00 bid price.
• ·Reverse stock split, if implemented, must be completed no later than 10 business days prior to September 7, 2026.
• ·Company eligible for extension based on meeting market value of publicly held shares and other initial listing requirements.

11-03-2026

GigaCloud Technology Inc's board of directors has scheduled the 2026 annual meeting of shareholders for July 10, 2026, with a record date of close of business on April 28, 2026. Shareholder proposals for inclusion in the proxy statement under Rule 14a-8 must be received by close of business on December 15, 2025, at the company's principal executive offices. Additional details on time and location will be in the proxy statement to be filed prior to the meeting.

• ·Proposals and notices must be sent to the Chief Executive Officer at 4388 Shirley Avenue, El Monte, CA 91731, USA, and comply with the company's memorandum and articles of association and applicable law.
• ·Class A ordinary shares, par value $0.05 per share, trade under symbol GCT on The Nasdaq Stock Market LLC.

11-03-2026

On March 6, 2026, the Board of Directors of Power Solutions International, Inc. (PSIX) approved the Power Solutions International, Inc. 2026 Phantom Unit Plan, a cash-settled incentive program designed to incentivize eligible service providers through Phantom Units tied to the fair market value of the Company's common stock. Phantom Units vest in three equal annual installments subject to continuous service, with accelerated vesting upon death, disability, or certain change in control events, and settle in cash within 60 days of vesting. No specific grant amounts or participant details were disclosed in the filing.

• ·Phantom Units determined by dividing award dollar value by average FMV over 30 trading days prior to grant date.
• ·Settlement based on average FMV over 30 trading days preceding vesting date.
• ·Accelerated vesting on involuntary termination or good reason resignation within 24 months post-change in control if awards assumed.
• ·Plan administered by Board or committee with full discretionary authority; subject to clawback policies.

11-03-2026

Ally Auto Assets LLC (Depositor) entered into a Trust Sale Agreement dated March 10, 2026, with Ally Auto Receivables Trust 2026-1 (Issuing Entity), conveying auto loan receivables previously purchased from Ally Bank in exchange for Notes and Certificates. The agreement includes representations and warranties on the receivables, repurchase obligations upon breach within specified timelines, and dispute resolution via ADR if repurchases are not fulfilled. No financial performance metrics or pool sizes are disclosed in the filing.

• ·Repurchase obligation triggered as of the last day of the second Monthly Period following breach discovery (or first at Depositor's election)
• ·Unfulfilled repurchase demands may lead to ADR referral within 180 days of Repurchase Request and within 30 days of unresolved notice
• ·ADR Proceedings (including Mediation) to occur in New York, NY, with mediator selection within 15 days

11-03-2026

IonQ, Inc. filed a prospectus supplement on March 11, 2026, to its S-3ASR Registration Statement (File No. 333-285279) for the resale of 2,562,642 shares of common stock by The Chancellor, Masters, and Scholars of the University of Cambridge under a Registration Rights Agreement dated March 10, 2026. The shares were issued in reliance on private offering exemptions under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D. No pricing, proceeds, or dilution impacts are disclosed in the filing.

• ·Registration Statement on Form S-3ASR filed February 26, 2025 (File No. 333-285279)
• ·Legal opinion provided by Paul, Weiss, Rifkind, Wharton & Garrison LLP (Exhibit 5.1)

11-03-2026

LaFayette Acquisition Corp., a SPAC, filed its 10-K annual report outlining its focus on acquisition targets with enterprise values of $500M to $1.5B, fundamentally sound financials, and positive cash flows. The filing highlights risks such as potential insider loans up to $1.5M convertible into units at $10.00 per unit, conflicts of interest, and impacts from debt or share issuances. Financial statements cover the year ended December 31, 2025, and the period from inception (June 7, 2024) through December 31, 2024, but specific performance metrics are not detailed in the provided content.

• ·Company inception date: June 7, 2024
• ·Financial statements include Balance Sheets as of December 31, 2025 and 2024; Statements of Operations, Changes in Shareholders’ Deficit, and Cash Flows for year ended December 31, 2025 and period from inception through December 31, 2024
• ·Potential non-interest bearing loans from initial shareholders or affiliates for transaction costs, with no written agreements yet

11-03-2026

Yotta Acquisition Corporation terminated its Business Combination Agreement, dated August 20, 2024, with DRIVEiT Financial Auto Group, Inc. and other parties, effective March 4, 2026, by providing written notice pursuant to Article 10. No separate termination agreement was entered into, ending the previously disclosed merger plans. This development represents a setback for the SPAC's primary business combination objective.

• ·Securities registered: Units (YOTAU), Common Stock (YOTA), Warrants (YOTAW), Rights (YOTAR) on Nasdaq Stock Market LLC
• ·Company is an emerging growth company

11-03-2026

News Corporation disclosed via 8-K filing information provided to the Australian Securities Exchange (ASX) regarding its $1 billion stock repurchase program authorizing purchases of Class A (NWSA) and Class B (NWS) common stock. The filing attaches Exhibits 99.1 and 99.2 with the specific ASX disclosures, noting daily transaction reporting requirements if any occur. No specific repurchase volumes or dates are detailed in the main filing body, with forward-looking statements on potential repurchases subject to market conditions.

• ·Date of earliest event reported: March 10, 2026
• ·Filing date: March 11, 2026
• ·Registrant details: Delaware incorporation, Commission File Number 001-35769, IRS EIN 46-2950970
• ·Principal executive offices: 1211 Avenue of the Americas, New York, New York 10036

11-03-2026

Cantor Equity Partners V, Inc. appointed Charlotte Blechman as a Class I director, Audit Committee member, and Compensation Committee member, effective March 10, 2026. Ms. Blechman brings extensive experience in marketing, branding, and public relations, including roles as Senior Managing Director at ACTUM since November 2025 and prior positions at Tom Ford Retail LLC and Barneys New York, as well as directorships at multiple SPACs. In connection with her appointment, the Board approved $50,000 annual compensation, paid quarterly.

• ·Ms. Blechman served as Chief Marketing Officer of Tom Ford Retail LLC from January 2017 to June 2023.
• ·No family relationships between Ms. Blechman and any director or executive officer.
• ·Company is an emerging growth company; Class A ordinary shares trade as CEPV on Nasdaq.

11-03-2026

C3.ai reported Q3 FY2026 total revenue of $53.3M, down 46% YoY from $98.8M, driven by subscription revenue declining 44% to $48.2M and professional services dropping 61% to $5.1M. While sales and marketing expenses rose 10% YoY to $67.2M and R&D remained nearly flat at $58.8M, gross profit plummeted 84% to $9.2M, resulting in a wider net loss of $133.4M (vs. $80.2M prior year). For the nine months FY2026, revenue fell 29% YoY to $198.7M, with net loss expanding 70% to $354.8M from $209.0M.

• ·Accounts receivable net: $123.6M as of Jan 31, 2026 (down from $137.2M at Apr 30, 2025)
• ·Deferred revenue current: $37.5M as of Jan 31, 2026 (up slightly from $36.6M)
• ·Net loss per share Q3 FY2026: $(0.94) (vs. $(0.62) prior year)

11-03-2026

Advasa Holdings, Inc., a Delaware-incorporated emerging growth company and holding company with operations in the US and Japan (SIC 7372), filed Pre-Effective Amendment No. 3 to its Form S-1 (Reg. No. 333-292013) on March 10, 2026, registering 485,469,380 shares of common stock (par value $0.00001) for resale by existing Registered Stockholders via a direct listing on Nasdaq Global Market under symbol 'ADBT', with no proceeds to the company and costs borne by it for compliance. The direct listing lacks traditional underwriting, potentially leading to higher volatility and no established public market, while a 10-for-1 forward stock split was effective December 4, 2025; trading is expected on or about [_____], 2026, subject to Nasdaq approval, which if denied would terminate the process. Investing involves a high degree of risk as highlighted in the prospectus.

• ·Registrant classified as non-accelerated filer, smaller reporting company, and emerging growth company.
• ·Principal executive offices: 1-2-7 Moto-Akasake, Minato-ku, Tokyo, 107-0051 Japan.
• ·Agent for service: Corporate Creations Network Inc., 1521 Concord Pike, Suite 201, Wilmington, Delaware 19803.
• ·Shares eligible under Rule 415 for delayed or continuous offering.

11-03-2026

Contango Ore, Inc. issued a press release on March 9, 2026, announcing that independent proxy advisor firms recommend stockholders vote 'For' the proposed arrangement to acquire Dolly Varden Silver Corporation. The deal, initially announced via an Arrangement Agreement on December 7, 2025, involves acquiring all Dolly Varden shares at an exchange ratio of 0.1652 Contango shares per Dolly Varden share through wholly-owned subsidiaries 1566004 B.C. Ltd. and 1566002 B.C. ULC. No financial metrics or performance comparisons were disclosed.

• ·Filing made under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits).
• ·Press release furnished as Exhibit 99.1, not deemed 'filed' under Section 18 of the Exchange Act.

11-03-2026

Sonos, Inc. filed a Certificate of Amendment to its Restated Certificate of Incorporation, granting the Board majority 'Whole Board' approval to adopt, amend, or repeal Bylaws, while allowing stockholders to do so by majority vote. It introduces a temporary classified board structure starting with the 2027 annual meeting (Class I and II terms ending 2028-2029), fully declassifying to annual elections by 2029, with enhanced removal protections (2/3 for cause until 2029, then majority with/without cause) and Board-filled vacancies. Article X now requires majority stockholder vote for future Certificate amendments; executed March 10, 2026, with no financial metrics disclosed.

• ·Restated Certificate of Incorporation originally filed March 17, 2025.
• ·Class I directors terms expire at 2028 annual meeting; Class II at 2029.
• ·From 2029 annual meeting, all directors elected annually for one-year terms.
• ·Vacancies or new directorships filled by majority of directors then in office, even if less than quorum.

11-03-2026

On March 6, 2026, CERO Therapeutics Holdings, Inc. issued and sold a convertible promissory note to Keystone Capital Partners, LLC for a purchase price of $750,000, with a principal face value of $937,500 and capacity to borrow up to an aggregate of $1M. The note carries 10% annual interest, matures on August 6, 2027, and is convertible into common stock at the lesser of $0.05 or 80% of the average of the five lowest intraday trading prices over the prior 20 trading days, subject to a 4.99% beneficial ownership limit. The transaction relies on exemptions under Section 4(a)(2) and Rule 506(b) of the Securities Act, with the company required to file a resale registration statement.

• ·Note form incorporated by reference from February 13, 2026 Form 8-K (Exhibit 4.1)
• ·Issued in reliance on Section 4(a)(2) of the Securities Act and Rule 506(b)
• ·Company to file Form S-1 or S-3 registration statement for resale of conversion shares

11-03-2026

AeroVironment's Q3 revenue surged 143% YoY to $408M, propelled by acquisitions introducing Space and Directed Energy ($53M) and Cyber and Mission Services ($76M) segments, with Precision Strike up 87% to $158M; nine-month revenue rose 145% to $1.3B. However, a $151M goodwill impairment, elevated SG&A (up 127% to $99M), and higher debt interest contributed to a Q3 net loss of $157M (vs $1.8M loss) and nine-month net loss of $241M (vs $27M profit), with Uncrewed Aircraft Systems revenue nearly flat nine-month YoY at $243M. Total assets expanded to $5.45B from $1.12B as of April 30, 2025, reflecting acquisitions funded by $2.6B stock issuance and $728M long-term debt.

• ·Cash used in operating activities nine months: $174M (vs $1M prior)
• ·Business acquisitions net of cash: $845M
• ·Proceeds from shares issued: $969M
• ·Proceeds from convertible debt: $727M
• ·Allowance for credit losses: $2.2M (up from $0.2M)

11-03-2026

TLGY Acquisition Corp held an extraordinary general meeting on March 10, 2026, where shareholders overwhelmingly approved the Business Combination with StablecoinX Assets Inc., including the SPAC Merger and advisory organizational document proposals, with 5,759,409 votes in favor and only 2,000 against across all proposals, representing nearly 100% approval among votes cast. Approximately 97% of entitled shares were present, constituting a quorum. However, shareholders redeemed 388,406 Class A Ordinary Shares from the trust account.

• ·Business Combination Agreement originally dated July 21, 2025, and amended January 21, 2026
• ·Registration Statement on Form S-4 declared effective February 17, 2026

11-03-2026

Aptevo Therapeutics Inc. announced new interim clinical data on March 10, 2026, for mipletamig in combination with venetoclax and azacitidine in newly diagnosed acute myeloid leukemia (AML) patients via a press release filed as Exhibit 99.1. No financial metrics or period-over-period comparisons were disclosed in the 8-K. The announcement highlights ongoing clinical development without specific quantitative outcomes provided.

• ·Filing date: March 11, 2026
• ·Date of earliest event reported: March 10, 2026
• ·Trial focus: newly diagnosed acute myeloid leukemia (AML) patients

11-03-2026

Boxabl Inc. appointed Shanmugam 'Shan' Palaniappan as Chief Technology Officer on March 10, 2026, to bolster software, automation, and AI capabilities as it advances toward a merger with FG Merger II Corp., per the agreement signed August 4, 2025. The move supports Boxabl's transition to an industrial-scale housing manufacturer, with no financial metrics disclosed. Forward-looking statements highlight potential benefits but note risks including merger approval delays and redemptions.

• ·Boxabl founded in 2017.
• ·Merger Agreement dated August 4, 2025, involves two-step merger with FG Merger Sub II Inc.; FGMC to become Surviving Pubco named BOXABL Inc.
• ·FGMC IPO prospectus filed January 29, 2025; Boxabl 10-K filed April 14, 2025.

11-03-2026

Pangaea Logistics Solutions Ltd. reported strong Q4 2025 results with revenue of $183.9M (up 25% YoY), Adjusted EBITDA of $28.7M (up 23% YoY), and TCE rates of $17,773/day (up 11% YoY), driven by 26% higher shipping days to 6,025; GAAP net income was $11.9M or $0.19/share. However, Adjusted EBITDA margin remained flat at 16% YoY, and full-year net income declined 33% to $19.4M from $28.9M despite 18% revenue growth to $632M. The company declared a $0.05/share dividend, repurchased $1M in stock, and agreed to sell the Bulk Xaymaca for $9.6M.

• ·Q1 2026 to date: 5,920 shipping days at average TCE $14,917/day
• ·Repaid $7.6M in finance leases and $4.2M in long-term debt in Q4 2025
• ·Operating cash flow Q4 2025: $15.1M

11-03-2026

Blue Water Acquisition Corp. IV (BWIV), a SPAC, filed an S-1/A registration statement on March 11, 2026, for its initial public offering of units at an offering price of $10.00 per unit. The filing includes extensive pro forma tables detailing net tangible book value per share across scenarios with and without overallotment option exercise and public shareholder redemptions at 0%, 25%, 50%, 75%, or 100% of maximum as of December 31, 2025. Founder shares were issued on August 1, 2025, and private placement units are referenced for the sponsor.

• ·Pro forma net tangible book value calculations exclude offering costs accrued or paid in advance, deferred underwriting commissions, overallotment liability, and redemptions
• ·Scenarios assume ordinary shares outstanding prior to offering and potential founder share forfeitures if overallotment not exercised

11-03-2026

Starz Entertainment Corp. (NASDAQ: STRZ) announced its Board unanimously adopted a limited-duration shareholder protection rights agreement (Rights Plan) effective March 10, 2026, set to expire March 10, 2027 unless extended. The plan issues one right per common share with a record date of March 20, 2026, becoming exercisable if any person or group acquires 17.5% or more beneficial ownership, entitling other shareholders to purchase shares at a 50% discount. It aims to protect long-term shareholder value and prevent control without fair compensation, applying equally to all shareholders without intent to deter fair offers.

• ·Rights agent: Computershare Investor Services Inc.
• ·Agreement dated March 10, 2026; full text in Form 8-K on EDGAR (www.sec.gov) and SEDAR+ (www.sedarplus.ca).
• ·Existing owners above 17.5% exempt from triggering but cannot acquire additional shares.

11-03-2026

Milestone Scientific Inc. filed an 8-K on March 11, 2026, under Items 5.03 and 9.01, disclosing amendments to its charter or bylaws along with attached exhibits. The filing, with a size of 4 MB, provides no specific financial metrics or performance data for analysis. No period-over-period comparisons or quantitative changes are detailed.

• ·Company CIK: 0000855683
• ·SIC: 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies)
• ·State of Incorporation: DE
• ·Fiscal Year End: December 31
• ·Business Address: 220 South Orange Avenue, Livingston, NJ 07039

11-03-2026

Johnson & Johnson (JNJ) filed Definitive Additional Proxy Materials (DEFA14A) on March 11, 2026, as a supplement to its proxy statement under Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee was required and is marked as Definitive Additional Materials. No specific proposals, financial data, or voting matters are detailed in the provided content.

• ·Filing categorized as Soliciting Material under § 240.14a-12

11-03-2026

Pono Capital Four, Inc., a Cayman Islands blank check company (SPAC), filed Amendment No. 2 to its S-1 registration statement on March 11, 2026, for an initial public offering of 15,000,000 units at $10.00 each, targeting gross proceeds of $150M, with underwriters' over-allotment option for 2,250,000 additional units. Sponsor Mehana Ventures LLC holds 7,392,857 Class B founder shares (purchased for $25,000 or ~$0.003/share, up to 964,286 forfeitable), maintaining ~30% post-IPO ownership on an as-converted basis, which will cause immediate and substantial dilution to public shareholders due to the nominal founder share price and anti-dilution protections. Private placements include 190,000 units ($1.9M) committed by sponsor and Private Placement Investor, plus potential 110,000 units ($1.1M) from non-managing sponsor investors.

• ·SEC file number: 333-293120
• ·Filer CIK: 0002108164
• ·EIN: 98-1907673
• ·Principal executive offices: Suite 210, 2nd Floor Windward III, Regatta Office Park, PO Box 500, Grand Cayman, KY-1106
• ·Business address: 643 Ilalo Street, #102, Honolulu, HI 96813
• ·IPO commencement: As soon as practicable after effective date
• ·Redemption price: Trust account net asset value per public share (net of taxes, excluding excise taxes)
• ·Non-managing sponsor investors not affiliated with management or sponsor; no obligation to vote for business combination

11-03-2026

Cintas Corporation announced a definitive agreement to acquire UniFirst Corporation for $310 per share in cash and stock, representing a $5.5B enterprise value at 8.0x run-rate trailing 12-month EBITDA, with expected $375M in operating cost synergies within four years and accretion to EPS by the end of the second full year post-closing. The deal enhances service capabilities for 1.5M customers across North America and is expected to close in H2 2026, subject to approvals. Cintas reported preliminary Q3 FY2026 revenue of $2.84B, up 8.9% YoY from $2.61B (organic growth 8.2%), with full results on March 25, 2026.

• ·Transaction multiple of 8.0x run-rate trailing 12 months EBITDA including $375M synergies.
• ·Net leverage ratio at close expected to be 1.5x debt to EBITDA.
• ·Croatti family entities control ~2/3 of UniFirst voting power and entered voting support agreement.
• ·UniFirst Q2 FY2026 results on April 1, 2026; no further conf calls or guidance due to transaction.

11-03-2026

Oracle reported strong Q3 revenue growth of 22% YoY to $17.2B, driven by Cloud revenues surging 44% to $8.9B, while total nine-month revenues rose 16% to $48.2B. However, Software revenues were nearly flat down 0.2% YoY at $17.7B for nine months, Hardware grew modestly 4% to $2.2B, and the company significantly increased capital expenditures to $39.2B alongside higher debt to $134.6B non-current notes payable. Net income for nine months jumped 42% to $12.8B, supported by operating cash flow up 18% to $17.4B.

• ·Diluted EPS nine months $4.38 vs $3.15 (+39%)
• ·Cash dividends declared per common share nine months $1.50 vs $1.20
• ·Unpaid capital expenditures $4.5B as of Feb 28, 2026
• ·Trade receivables net $10.7B vs $8.6B
• ·Restructuring expenses nine months $961M vs $220M

11-03-2026

Smurfit Westrock plc filed DEFA14A additional proxy materials notifying shareholders of the 2026 Annual General Meeting on May 1, 2026, in Dublin, Ireland. Key proposals include election of 12 director nominees, advisory vote on named executive officer compensation, ratification of KPMG as auditor for fiscal year ending December 31, 2026, and renewals of board authorities to issue shares, opt-out of pre-emption rights, and re-issue treasury shares. The Board recommends voting FOR all proposals; materials available online with voting deadline April 30, 2026.

• ·Proxy materials request deadline: April 16, 2026
• ·Voting deadline: 12:00 p.m. Dublin Time / 7:00 a.m. Eastern Time on April 30, 2026
• ·AGM location: Minerva Suite, RDS Merrion Road, Ballsbridge, Dublin 4, D04 AK83, Ireland
• ·2025 Annual Report and 2025 Irish Statutory Annual Report referenced as available online

11-03-2026

Pelican Acquisition Corporation clarified that, as a Cayman Islands exempted company, it is not a 'covered corporation' under Section 4501 of the Internal Revenue Code, so the 1% excise tax on stock repurchases is not expected to apply to redemptions of ordinary shares in connection with the shareholder vote on its proposed Business Combination with Greenland Exploration Limited and March GL Company. This means public shareholders electing to redeem should receive full cash amounts without tax reduction. However, this is based on current guidance, and future U.S. Treasury or IRS regulations could alter this, potentially retroactively.

• ·Company address: 1185 Avenue of the Americas, Suite 349, New York, NY 10036.
• ·Securities listed on Nasdaq: Units (PELIU), Ordinary shares (PELI, $0.0001 par value), Rights (PELIR).
• ·Emerging growth company status confirmed.
• ·Press Release dated March 11, 2026 attached as Exhibit 99.1.

11-03-2026

Flutter Entertainment plc filed an 8-K on March 11, 2026, under Items 7.01 and 9.01, disclosing an RNS Announcement regarding its share repurchase program, released via the Regulatory News Service in London to comply with UK Financial Conduct Authority’s Disclosure Guidance and Transparency Rules. The announcement is furnished as Exhibit 99.1. No specific financial metrics, amounts, or performance data were detailed in the filing.

11-03-2026

Target Hospitality reported FY2025 revenue of $320.6M, down 17% YoY from $386.3M, net loss of $37.1M versus $71.4M profit, and Adjusted EBITDA of $53.2M, a 73% decline from $196.7M, primarily due to the PCC Contract termination effective February 2025, with utilization dropping to 51% from 83%. Q4 revenue increased 7% YoY to $89.8M from $83.7M, driven by new Workforce Hub and Dilley Contracts, but Adjusted EBITDA fell to $6.5M from $41.1M. The company secured over $740M in multi-year contracts since February 2025, including new $129M West Texas Power Community (1,400 beds) and $23M Pecos Power Community (400 beds), with 2026 outlook of $320-330M revenue and $60-70M Adjusted EBITDA.

• ·Zero net debt and $8M cash as of Dec 31, 2025.
• ·FY2026 outlook: Capital Expenditures $65-75M, excluding acquisitions.
• ·HFS-South Q4 utilization 69% vs 73% YoY.
• ·Government segment Q4 adjusted gross profit $5.4M vs $37.7M YoY.
• ·WHS segment Q4 revenue $39.7M (new) with $9.1M adjusted gross profit.

11-03-2026

TSS, Inc. reported full-year 2025 revenue of $245.7 million, up 66% YoY, driven by Procurement (+68%) and Systems Integration (+78%) growth, though Facilities Management revenues declined 1% YoY to $7.9 million. Q4 2025 revenue rose 22% YoY to $60.9 million, with gross profit up 57% to $11.3 million and Adjusted EBITDA up 132% to $7.9 million. Net income for the year surged 153% to $15.1 million, with diluted EPS at $0.56, up from $0.24; the company also extended its AI rack integration agreement with its largest customer and guided 2026 Adjusted EBITDA to $20-22 million.

• ·Amended long-term AI rack integration agreement with largest customer, executed December 2025, effective November 1, 2025, extending term by two years.
• ·2026 Adjusted EBITDA outlook: $20-22 million.
• ·Cash increased to $85.5 million from $23.2 million YoY.
• ·Total assets grew to $184.9 million from $96.6 million as of Dec 31, 2025.

11-03-2026

CRISPR Therapeutics AG announced on March 10, 2026, the commencement of a private offering of $350M aggregate principal amount of convertible senior notes due 2031 to qualified institutional buyers under Rule 144A. The offering was upsized on March 11, 2026, to $550M aggregate principal amount, indicating strong investor demand. Press releases are attached as Exhibits 99.1 and 99.2.

• ·Offering subject to market conditions and other factors
• ·Notes offered pursuant to Rule 144A under the Securities Act of 1933

11-03-2026

Minerva Neurosciences reported FY 2025 financial results with $80M gross proceeds from an October 2025 private placement, boosting cash to $82.4M from $21.5M at year-end 2024, and plans to initiate a confirmatory Phase 3 trial for roluperidone in Q2 2026 with topline data in 2H 2027. However, GAAP net loss widened dramatically to $293.4M for FY 2025 from $1.4M net income in 2024, driven by $321.5M non-cash loss on convertible preferred stock and warrant issuance, while R&D expenses declined 51% YoY to $5.8M but G&A rose 12% in Q4 to $2.8M. Non-GAAP adjusted net loss improved to $16.0M from $19.3M for the full year.

• ·Warrant liability fair value at Dec 31, 2025: $171.5M, with $45.4M non-cash gain on change in fair value for FY 2025.
• ·Non-GAAP total liabilities: $2.3M at Dec 31, 2025 vs $2.8M at Dec 31, 2024 (slight decline).
• ·Q4 GAAP net loss per share: $25.51 vs $0.56 prior year; FY GAAP net loss per share: $34.67 vs $0.19 net income per share prior year.

11-03-2026

Acacia Research Corporation reported record full-year 2025 revenue of $285.2 million, up 133% YoY from $122.3 million, driven by Manufacturing Operations and Intellectual Property, alongside full-year GAAP Net Income of $21.7 million. Q4 revenue rose 3% YoY to $50.1 million with Total Company Adjusted EBITDA of $17.4 million, up from $4.9 million; however, Energy Operations revenue declined 8% YoY in Q4 to $16.0 million, Industrial Operations revenue fell 11% YoY to $7.3 million and full-year Industrial revenue dropped 7% YoY to $28.3 million, while Industrial Q4 Adjusted EBITDA decreased 34% YoY.

• ·Operated Segment Adjusted EBITDA full-year 2025: $96.4M, up from $35.7M in 2024.
• ·Manufacturing Operations full-year revenue: $114.8M vs $23.2M in 2024.
• ·Intellectual Property Operations full-year revenue: $78.4M, up ~301% YoY.
• ·Q4 Manufacturing Operations Adjusted EBITDA: $1.1M vs $2.4M prior year (decline).
• ·Full-year Free Cash Flow: $64.7M.

11-03-2026

Ironwood Pharmaceuticals, Inc. notified Wells Fargo Bank, as administrative agent, on March 10, 2026, that it satisfied the liquidity conditions under the Credit Agreement dated May 21, 2023 (as amended September 27, 2024). As a result, the maturity date for the revolving credit facility remains December 31, 2028, subject to other terms and conditions.

• ·Credit Agreement originally dated May 21, 2023, and amended by Amendment No. 1 on September 27, 2024.
• ·Filing signed and dated March 11, 2026.

11-03-2026

Serve Robotics reported strong revenue growth with Q4 2025 at $0.9M (up ~400% YoY from $0.2M) and full year 2025 at $2.7M (exceeding $2.5M guidance and up 46% YoY from $1.8M), scaling fleet to 2,000 robots across 20 cities in 6 metro areas while achieving 99.8% delivery completion. However, net losses widened dramatically to $101M for full year 2025 from $39M in 2024, with Q4 loss at $34M amid surging operating expenses ($97M vs $38M prior year) and gross losses. The company raised 2026 revenue guidance to $26M and maintained $260M liquidity, bolstered by four strategic acquisitions diversifying into healthcare and AI.

• ·Daily Active Robots increased to 547 in Q4 2025 from 312 in Q3 2025 and 257 in Q4 2024.
• ·Recurring revenues grew over 4x from ~$0.2M in Q1 2025 to over $0.8M in Q4 2025.
• ·Software services revenue: $1.0M full year 2025 vs $1.2M in 2024 (slight decline).
• ·Net cash used in operating activities: $80M for both full year 2025 and 2024.

11-03-2026

Ryder System, Inc. filed a DEFA14A Definitive Additional Proxy Materials on March 11, 2026, as soliciting material under Rule 240.14a-12. The filing indicates no fee was required and contains no substantive financial data, metrics, or performance details. This appears to be supplemental proxy information ahead of a shareholder meeting.

11-03-2026

Smith Douglas Homes reported full-year 2025 home closings up 1% YoY to 2,908, achieving a record, with active communities increasing 28% to 100 and controlled lots up 14% to 22,268; however, home closing revenue was slightly down 0.4% to $971.1M and gross margin contracted sharply to 21.8% from 26.2%, while pre-tax income fell to $70.9M from $116.9M. In Q4 2025, home closings decreased 7% to 780, revenue dropped 9% to $260.4M with gross margin at 19.9% versus 25.5%, and net new orders declined 7% to 532 amid affordability pressures and competitive discounting. Debt-to-book capitalization rose to 9.0% from 0.8%, though management noted encouraging early 2026 traffic.

• ·Southeast segment Q4 revenue down 15% YoY to $164.7M; Central up 1% to $95.8M.
• ·FY Southeast revenue flat at $610.8M, Central down 2% to $360.3M.
• ·Backlog contract value down 27% YoY to $172.5M.
• ·Net cash used in operating activities $31.3M in FY 2025 vs provided $19.1M prior.
• ·Cancellation rate improved to 11.1% FY vs 12.1% prior.

11-03-2026

Vistagen Therapeutics, Inc. implemented a Board-approved 20% workforce reduction on March 5, 2026, aimed at disciplined cash management while prioritizing the PALISADE Program clinical studies for fasedienol in social anxiety disorder. The company anticipates immaterial costs from severance and benefits, with a cash runway extending into 2027, though additional unforeseen costs may arise. Topline results from the PALISADE-4 Phase 3 trial are expected in the first half of 2026.

• ·Affected employees may receive cash severance and temporary healthcare coverage upon signing a separation agreement with general release of claims.
• ·Filing date: March 11, 2026.
• ·Costs incurred expected to be immaterial, but additional costs may occur due to associated events.